Heron Therapeutics (HRTX) Other financing activities (2018 - 2026)
Heron Therapeutics (HRTX) reported Other financing activities of -$51000.0 for Q1 2026, down 179.69% on a YoY basis from $64000.0 in Q1 2025, and up 96.28% quarter-over-quarter from -$1.4 million in Q4 2025.
Heron Therapeutics (HRTX) Other financing activities (2018 - 2026) Analysis & Trends
Heron Therapeutics has reported Other financing activities for 9 years, with the latest figure at -$51000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other financing activities fell 179.69% year-over-year to -$51000.0; the trailing twelve-month figure through Mar 2026 stood at -$1.3 million (down 459.27% YoY), and the FY2025 full-year result was $160000.0, down 47.19% from the prior year.
- Other financing activities for Q1 2026 stood at -$51000.0, up from -$1.4 million in the prior quarter.
- The five-year high for Other financing activities was $318000.0 in Q2 2024, with the low at -$1.4 million in Q4 2025.
- Historically, Other financing activities has averaged -$196764.7 across 5 years, with a median of -$51000.0 in 2025.
- The largest YoY upside for Other financing activities was 481.82% in 2025 against a maximum downside of 3415.38% in 2025.
- Heron Therapeutics' Other financing activities stood at -$215000.0 in 2022, then surged by 99.07% to -$2000.0 in 2023, then tumbled by 1850.0% to -$39000.0 in 2024, then sank by 3415.38% to -$1.4 million in 2025, then jumped by 96.28% to -$51000.0 in 2026.
- The last three Other financing activities figures came in at -$51000.0 (Q1 2026), -$1.4 million (Q4 2025), and -$51000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Heron Therapeutics | 85.57 Mn | 55.60 Mn | 24.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -51,000.00 |
| Mar 31, 2026 | -51,000.00 |
| Dec 31, 2025 | -1.37 Mn |
| Dec 31, 2025 | -1.37 Mn |
| Sep 30, 2025 | -51,000.00 |
| Sep 30, 2025 | -51,000.00 |
| Jun 30, 2025 | 194,000.00 |
| Jun 30, 2025 | 194,000.00 |
| Mar 31, 2025 | 64,000.00 |
| Mar 31, 2025 | 64,000.00 |
| Dec 31, 2024 | -39,000.00 |
| Dec 31, 2024 | -39,000.00 |
| Sep 30, 2024 | 13,000.00 |
| Sep 30, 2024 | 13,000.00 |
| Jun 30, 2024 | 318,000.00 |
| Jun 30, 2024 | 318,000.00 |
| Mar 31, 2024 | 11,000.00 |
| Mar 31, 2024 | 11,000.00 |
| Dec 31, 2023 | -2,000.00 |
| Dec 31, 2023 | -2,000.00 |